These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 19243652
1. Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers. Rivas I, Latorre I, Sanvisens A, Domínguez J, Tor J, Prat C, Rey-Joly C, Muga R. Epidemiol Infect; 2009 Sep; 137(9):1342-7. PubMed ID: 19243652 [Abstract] [Full Text] [Related]
2. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Vassilopoulos D, Stamoulis N, Hadziyannis E, Archimandritis AJ. J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793 [Abstract] [Full Text] [Related]
3. Tuberculosis infection in drug users: interferon-gamma release assay performance. Grimes CZ, Hwang LY, Williams ML, Austin CM, Graviss EA. Int J Tuberc Lung Dis; 2007 Nov; 11(11):1183-9. PubMed ID: 17958979 [Abstract] [Full Text] [Related]
4. Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection. Petrucci R, Abu Amer N, Gurgel RQ, Sherchand JB, Doria L, Lama C, Ravn P, Ruhwald M, Yassin M, Harper G, Cuevas LE. Pediatr Infect Dis J; 2008 Dec; 27(12):1073-7. PubMed ID: 18946366 [Abstract] [Full Text] [Related]
5. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, Rakus Z, Gottschalk R, Stark S, Brodt HR, Staszewski S. AIDS; 2008 Nov 30; 22(18):2471-9. PubMed ID: 19005270 [Abstract] [Full Text] [Related]
7. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR. J Infect Dis; 1999 May 30; 179(5):1297-300. PubMed ID: 10191241 [Abstract] [Full Text] [Related]
8. Interferon-gamma release assays and TB diagnosis. Drug Ther Bull; 2009 Jun 30; 47(6):67-70. PubMed ID: 19494343 [Abstract] [Full Text] [Related]
10. Comparison of tuberculin skin test with a whole-blood interferon gamma assay and ELISA, in HIV positive children and adolescents with TB. Stavri H, Ene L, Popa GL, Duiculescu D, Murgoci G, Marica C, Ulea I, Cus G, Popa MI. Roum Arch Microbiol Immunol; 2009 Jun 30; 68(1):14-9. PubMed ID: 19507622 [Abstract] [Full Text] [Related]
11. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. Winje BA, Oftung F, Korsvold GE, Mannsåker T, Ly IN, Harstad I, Dyrhol-Riise AM, Heldal E. BMC Infect Dis; 2008 Oct 17; 8():140. PubMed ID: 18928541 [Abstract] [Full Text] [Related]
14. Clinical utility of a T cell-based assay in the diagnosis of extrapulmonary tuberculosis. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Respirology; 2009 Mar 17; 14(2):276-81. PubMed ID: 19210655 [Abstract] [Full Text] [Related]
15. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Pediatrics; 2009 Jan 17; 123(1):30-7. PubMed ID: 19117857 [Abstract] [Full Text] [Related]